Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04449445 · ClinicalTrials.gov registry record · NA

Perioperative Nutritional Optimization in Head and Neck Cancer Patients

A NA study of Head and Neck Cancer, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT04449445 is a NA study of Head and Neck Cancer that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 300 participants, above the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04449445, a NA study of Head and Neck Cancer, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

To determine whether nutritional optimization in head and neck cancer patients undergoing major surgery will decrease post-operative wound complications. The Investigators hypothesize that nutritional supplementation with Nestle Impact Advanced Recovery (AR) will decrease the rate of wound complications after surgery

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Isocaloric and iso-nitrogenous standard enteral tube feeds
  • DIETARY_SUPPLEMENT Nestle IMPACT AR

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-05-10
Est. Completion 2026-11
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT04449445

The ClinicalTrials.gov registry entry for NCT04449445 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (15% higher). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Isocaloric and iso-nitrogenous standard enteral tube feeds is the first listed.

NCT04449445 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04449445 about?

NCT04449445 is a clinical study titled "Perioperative Nutritional Optimization in Head and Neck Cancer Patients". To determine whether nutritional optimization in head and neck cancer patients undergoing major surgery will decrease post-operative wound complications. The Investigators hypothesize that nutritional supplementation with Nestle Impact Advanced Recovery (AR) will decrease the rate of wound complicat...

What is the current status of trial NCT04449445?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-05-10. Estimated completion is 2026-11.

What conditions does trial NCT04449445 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT04449445?

The interventions under investigation include: Isocaloric and iso-nitrogenous standard enteral tube feeds (DIETARY_SUPPLEMENT), Nestle IMPACT AR (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04449445?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04449445 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.